Tepotinib
About
Therapy type: Targeted therapy
Therapy strategy: MET inhibition
Mappings
NCI Thesaurus: Tepotinib (ncit:C88314)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Tepotinib | |
| Sensitivity (+) | MET Exon 14 (Deletion) | Non-Small Cell Lung Cancer | Tepotinib | |
| Sensitivity (+) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Tepotinib | |
| Sensitivity (+) | MET Exon 14 (Deletion) | Non-Small Cell Lung Cancer | Tepotinib | |
| Sensitivity (+) | MET Exon 14 (Splice Site) | Non-Small Cell Lung Cancer | Tepotinib | |
| Sensitivity (+) | MET Exon 14 (Deletion) | Non-Small Cell Lung Cancer | Tepotinib |